HUGE: With a Rocket
It is always nice to see a client do well. FSD Pharma (C.HUGE) is blazing a trail in the already hot marijuana space.
Tag: FSD Pharma
FSD Pharma: Indoor, Medical Grade, Cannabis
As the companies come up to the starting gate for the great Canadian recreational cannabis sweepstakes we are seeing huge interest in the sector. The investment of 5 billion dollars in Canopy Growth by Constellation Beverages re-ignited the marijuana stock market in Canada. All of a sudden, Canada’s world-wide lead in the creation and financing of cannabis businesses looked to have an international scope.
Canadian Cannabis: Strategic Options
As the various Canadian Cannabis companies jockey for position in the recreational marijuana market it’s time to consider which are best placed to meet the market strategically.
Recreational Cannabis in Canada
Here is another in my series of articles on the recreational marijuana industry in Canada. There is no doubt a lot of money to be made selling legal pot but the federal and provincial governments are not making it easy. The biggest hole in the regulatory scheme is the postponement of regulations dealing with edibles. In the US edibles have constituted up to 50% of the legal market. Companies have to adapt.
Marijuana Market Segmentation
I am writing a series of articles over at Seeking Alpha on the ins and outs of the Canadian marijuana market and the public companies which are working in this space. Article #2 is a worms eye view of the various sorts of users who make up that market including people who might grow their own.
Canadian Cannabis 2.0
Over at Seeking Alpha I am going to be taking a deep dive into the realities of the new Canadian recreational marijuana business.
FSD Pharma secures exclusive rights in Canada for line of proprietary products and premium access to cannabinoid science research platform in Israel
FSD Pharma Inc. (the “Company”) (CSE: HUGE), is pleased to announce that its wholly- owned subsidiary FV Pharma Inc (“FV Pharma”) have entered into a strategic alliance with SciCann Therapeutics Inc. (“SciCann”) by executing a binding Memorandum of Understanding (the “MOU“) dated May 28, 2018, pursuant to which FV Pharma shall invest up to $3M in SciCann for a 15% equity stake.
FSD Pharma Announces Listing on the Canadian Securities Exchange
FSD Pharma Inc. (formerly, Century Financial Capital Group Inc., the “Corporation“) is pleased to announce that the Canadian Securities Exchange (“CSE“) has provided final approval to list the Corporation’s class B subordinate voting shares (the “Class B Subordinate Voting Shares“) for trading. Trading of the Class B Subordinate Voting Shares will commence on May 29, 2018 under the symbol “HUGE”. Information about the Corporation can be found in the Corporation’s listing statement dated May 28, 2018, which is located on the Corporation’s profile at www.sedar.com and on the CSE website.